DOWLING & PARTN Has Positive View of MetLife FY2027 Earnings

MetLife, Inc. (NYSE:METFree Report) – Equities research analysts at DOWLING & PARTN boosted their FY2027 earnings per share estimates for shares of MetLife in a report released on Friday, August 14th. DOWLING & PARTN analyst J. Hurwitz now anticipates that the financial services provider will post earnings per share of $10.85 for the year, up from their prior estimate of $10.75. The consensus estimate for MetLife’s current full-year earnings is $9.70 per share.

Several other research firms have also recently issued reports on MET. Barclays increased their target price on MetLife from $94.00 to $97.00 and gave the stock an “overweight” rating in a research report on Thursday, August 6th. TD Cowen upped their price target on MetLife from $87.00 to $105.00 and gave the stock a “buy” rating in a research note on Wednesday, July 22nd. UBS Group lifted their price objective on shares of MetLife from $102.00 to $105.00 and gave the company a “buy” rating in a research report on Wednesday, July 8th. Mizuho raised their target price on shares of MetLife from $95.00 to $102.00 and gave the company an “outperform” rating in a research note on Thursday, July 9th. Finally, JPMorgan Chase & Co. lifted their price target on shares of MetLife from $106.00 to $108.00 and gave the company an “overweight” rating in a report on Tuesday, August 11th. One research analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $101.07.

Get Our Latest Research Report on MET

MetLife Trading Down 1.0%

Shares of MET stock opened at $96.73 on Tuesday. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.20 and a current ratio of 0.20. The stock has a fifty day simple moving average of $91.77 and a two-hundred day simple moving average of $81.72. The firm has a market capitalization of $62.24 billion, a PE ratio of 18.53, a PEG ratio of 0.75 and a beta of 0.78. MetLife has a 52-week low of $67.33 and a 52-week high of $100.93.

MetLife (NYSE:METGet Free Report) last released its earnings results on Wednesday, August 5th. The financial services provider reported $2.43 earnings per share for the quarter, beating the consensus estimate of $2.30 by $0.13. The company had revenue of $13.52 billion for the quarter, compared to the consensus estimate of $19.67 billion. MetLife had a return on equity of 23.39% and a net margin of 4.57%.MetLife’s quarterly revenue was up 10.5% compared to the same quarter last year. During the same period in the previous year, the business earned $2.02 earnings per share.

Hedge Funds Weigh In On MetLife

Several institutional investors have recently bought and sold shares of MET. BlackRock Inc. bought a new position in shares of MetLife in the 2nd quarter valued at about $4,381,692,000. Pzena Investment Management LLC purchased a new stake in MetLife during the second quarter valued at approximately $941,792,000. Norges Bank bought a new stake in shares of MetLife in the 4th quarter valued at approximately $639,986,000. Vanguard Group Inc. boosted its holdings in shares of MetLife by 12.1% in the 4th quarter. Vanguard Group Inc. now owns 72,555,335 shares of the financial services provider’s stock worth $5,727,518,000 after purchasing an additional 7,805,814 shares during the period. Finally, Bank of America Corp DE bought a new position in shares of MetLife during the 2nd quarter valued at approximately $455,424,000. Institutional investors own 94.99% of the company’s stock.

MetLife Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 8th. Investors of record on Tuesday, August 4th will be given a $0.5925 dividend. This represents a $2.37 annualized dividend and a yield of 2.5%. The ex-dividend date is Tuesday, August 4th. MetLife’s payout ratio is currently 45.40%.

MetLife announced that its Board of Directors has initiated a share repurchase program on Wednesday, August 5th that authorizes the company to repurchase $3.00 billion in shares. This repurchase authorization authorizes the financial services provider to repurchase up to 4.8% of its stock through open market purchases. Stock repurchase programs are usually an indication that the company’s leadership believes its shares are undervalued.

About MetLife

(Get Free Report)

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.

Featured Articles

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.